(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of 16.94% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Biolife Solutions's revenue in 2026 is $102,818,000.On average, 11 Wall Street analysts forecast BLFS's revenue for 2026 to be $5,714,259,295, with the lowest BLFS revenue forecast at $5,438,425,485, and the highest BLFS revenue forecast at $5,982,757,100. On average, 10 Wall Street analysts forecast BLFS's revenue for 2027 to be $6,721,737,398, with the lowest BLFS revenue forecast at $6,326,571,229, and the highest BLFS revenue forecast at $7,050,879,516.
In 2028, BLFS is forecast to generate $8,200,187,060 in revenue, with the lowest revenue forecast at $7,828,496,109 and the highest revenue forecast at $8,494,605,418.